SCHEMBL10587238

SCHEMBL10587238

CSc1nc(C)c(O)n1Cc1ccc(N)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ POLB P06746 2/20 0.37
▸ ATM Q13315 1/20 0.36
▸ APOBEC3G Q9HC16 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ MDM4 O15151 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ MDM2 Q00987 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ BRAF P15056 1/20 0.34
▸ HTT P42858 2/20 0.33
▸ TSHR P16473 1/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33
▸ FEN1 P39748 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL256 0.70 POLB (0.74) POLBTP53HTT
SCHEMBL5731691 0.66 TLR7 (0.43) ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10
SCHEMBL14725062 0.63 BRAF (0.48) MAPTPOLBATMAPOBEC3GALDH1A1
SCHEMBL10918659 0.62 POLB (0.43) MAPTPOLBATMAPOBEC3GALDH1A1
SCHEMBL27877818 0.62 LMNA (0.42) MAPTL3MBTL1POLBALDH1A1KDM4E
SCHEMBL4793000 0.61 SOS1 (0.39) MAPTALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL7446291 0.61 HPGD (0.50) MAPTPOLBALDH1A1KDM4EHPGD
SCHEMBL3974904 0.61 TNF (0.77) MAPTL3MBTL1ALDH1A1KDM4EHPGD
SCHEMBL13102481 0.58 KLKB1 (0.54) MAPTL3MBTL1LMNA
SCHEMBL6163018 0.58 NR4A1 (0.62) MAPTL3MBTL1POLBALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0324377-A2 Angiotensin II receptor blocking imidazoles and combinations thereof with diuretics and NSaids E.I. DU PONT DE NEMOURS AND COMPANY (US) 1989-07-19 — — EP disclosed
Send feedback